AstraZeneca’s release Monday of encouraging data about its coronavirus vaccine from its U.S. trial raised hopes that the drug company could put a troubled rollout behind it. But just hours after its announcement, American officials issued an unusual statement expressing concern the company had included “outdated information” from its study and that it may have provided “an incomplete view of the efficacy data.”
Related posts
-
Activate Games bringing ‘unique’ gaming to Naperville
Activate Games is bringing interactive gaming to Naperville. -
Federal judge strikes down Illinois assault weapons ban, setting up likely appeal
A federal judge in East St. Louis on Friday struck down Illinois’ assault weapons ban on... -
Hoffman Estates sees season end with second round loss to Lincoln-Way Central
Talk about making up for lost time.